BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 21, 2010
View Archived Issues
Ramucirumab is tolerated in patients with advanced HCC in ongoing phase II trial
Read More
Almirall identifies new naphthyridine N-oxide as anti-inflammatory agent
Read More
Scientists reveal predictors of adverse events associated with losartan therapy for heart failure
Read More
Novel ACAT-1 inhibitors presented by Galderma
Read More
Scientists create Maraba MG1 virus strain with increased tumor-selective potency
Read More
NFL-10808 silences presynaptic serotonin 5-HT1A receptors and has antidepressant effects in vivo
Read More
Daiichi Sankyo identifies new inhibitors of HSP 90 ATPase activity
Read More
Ligand Pharmaceuticals and Proximagen collaborate on chemokine CXCR4 receptor target
Read More
Trial of TT-223/GLP-1 analogue combination in type 2 diabetes does not meet endpoints
Read More
RaQualia Pharma claims new motilin receptor agonists
Read More
Vantia identifies new vasopressin V1A receptor antagonists
Read More
LigoCyte begins phase I trial of bivalent intramuscular norovirus vaccine
Read More
Novel COX-1 inhibitors described by Japanese scientists
Read More
ImmunoCellular Therapeutics begins phase II glioblastoma study of ICT-107
Read More
Ablynx reports follow-up data from phase I study of ALX-0141
Read More
Faron Pharma advances FP-1201 into second part of trial in acute lung injury
Read More
Novartis Europharm withdraws Rasival MAA for essential hypertension
Read More
Phase III Northera trial meets endpoint in neurogenic orthostatic hypotension
Read More
Icagen suspends enrollment in photosensitivity study of ICA-105665
Read More
Boehringer Ingelheim begins phase III afatinib trial in breast cancer
Read More
EMA updates nevirapine label for patients with HIV-1 infection
Read More
Synvisc is approved in Japan for osteoarthritis of the knee
Read More
Hybrigenics reports phase IIa data on inecalcitol/docetaxel combination in prostate cancer
Read More
Endo Pharma completes tender offer for Penwest Pharma shares
Read More
SCH-527123 is safe and efficacious in phase II trial in COPD
Read More